Back to Journal

SM Virology

Serosurveillance of Foot-and-Mouth Disease in Ruminant Population of Karnataka, India

[ ISSN : 3067-9974 ]

Abstract Keywords Citation Introduction Materials and Methods Results Discussion Acknowledgement References
Details

Received: 22-Apr-2016

Accepted: 11-May-2016

Published: 13-May-2016

Raveendra Hegde1*, Madhusudan Hosamani2 , Sreevatsava V1 , Rashmi KM1 , Srikanth Kowalli1 , K Nagaraja1 , NK Dharanesha1 , CM Seema1 , GV Nagaraj1 , K Srikala1 , KJ Sudharshana1 , SheshaRao1 , Rajashekar B1 , P Giridhara1 , and SM Byregowda1

1Institute of Animal Health and Veterinary Biologicals, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru, India

2ICAR-Indian Veterinary Research Institute, Bengaluru, India

Corresponding Author:

Raveendra Hegde, Institute of Animal Health and Veterinary Biologicals, Karnataka Veterinary, Animal and Fisheries Sciences University, Hebbal, Bengaluru, India, Tel: 91- 80- 23414592.

Keywords

Foot and mouth Disease (FMD); Nonstructural Proteins (NSP); Structural Proteins (SP); Serosurveillance

Abstract

Foot-and-Mouth Disease (FMD) is endemic in India and three serotypes viz, O, A, and Asia-1are prevalent in the country. In the current study a total of 7923 serum samples were collected randomly from 4639 cattle, 1363 buffaloe, 1187 sheep and 734 goats from different districts of Karnataka state, India. The samples were screened for antibodies against Non-Structural Proteins (NSPs) and Structural Proteins (SPs) of FMD virus to gather evidence with respect to the FMD virus circulation. The study revealed NSP antibodies in 33% bovines and 16% small ruminants. Higher level of NSP antibodies was observed in cattle (35%), buffaloes (27%), goats (23%) and lower prevalence in sheep (12%).The antibodies against SP was observed in 78% bovines and 18% small ruminants. The study reiterates the importance of strengthening of FMD surveillance in small ruminants as they could pose a potential risk of virus transmission to cattle.

Keywords

Foot and mouth Disease (FMD); Nonstructural Proteins (NSP); Structural Proteins (SP); Serosurveillance

Citation

Hegde R, Hosamani M, Sreevatsava V, Rashmi KM, Kowalli S, Nagaraja K, et al. Serosurveillance of Foot-and-Mouth Disease in Ruminant Population of Karnataka, India. SM Virol. 2016; 1(2): 1006.

Introduction

Foot-and-Mouth Disease (FMD) remains a serious threat to the livestock population of India where the disease is endemic. Three (O, A and Asia-1) of the seven serotypes of Foot-and Mouth Disease Virus (FMDV) are prevalent in India, while serotype C has not been detected in the country since 1995 [1]. The occurrence of the disease results in damaging consequences for the livelihoods of local farmers due to impacts upon productivity, food security, and loss of income. India has ~528 million FMD susceptible livestock population (19th Livestock census of India), and the direct economic loss on account of FMD is more than Rs. 20000 crores per annum (~USD 3.2 billion) [2]. Karnataka, the seventh largest state in India has a sizeable proportions of livestock (9.5 million cattle, 3.4 million buffalo, 9.5 million sheep, 4.8 million goats and 0.3 million pigs) susceptible to FMD. FMD outbreaks are regularly recorded in the state of Karnataka and serotype O has been the most prevalent one. Intermittent circulation of FMDV serotypes A and Asia-1 has also been confirmed in the state [3]. Since September 2011, cattle and buffalo (bovines) population of Karnataka state are regularly vaccinated with a trivalent vaccine containing all the three FMDV serotypes circulating in the country, at 6 monthly intervals under the government funded National FMD control programme (FMDCP) [1]. The herd immunity among the vaccinated population against all the three serotypes in the state of Karnataka had increased from 5% to 59% at the end of IVth phase of vaccination leaving 61% population still susceptible to FMD outbreaks [3]. Sheep and goat population are not vaccinated against FMD under the FMD-CP. Although length and size of FMD outbreaks has been significantly reduced due to systematic vaccinations, an abrupt increase in FMD incidences due to serotype O was recorded in the year 2013 [4-6] involving all the species (cattle, buffaloe, sheep, goat, pig) throughout the southern peninsular India (Karnataka, Tamil Nadu, Kerala, Andra Pradesh, Pondicherry).

Earlier, serological survey for antibodies against FMDV was restricted to bovine population only [7] which revealed the prevalence of antibody against both the Nonstructural Proteins (NSP) and Structural Proteins (SP) in 21% and 33% of the animal population in Karnataka state. In this study, all the four susceptible ruminant species (cattle, buffaloe, sheep and goat) with or without the history of recent outbreaks were included to determine the prevalence of antibodies against FMDV SP and NSP. Further, clinical materials collected from FMD suspected animals were tested in antigen differentiating ELISA to identify the prevalent serotypes.

Materials and Methods

Study Area and Design

Karnataka, the seventh largest state in India (191.791km2 area, 5.8 % of the country), is situated between 11o40’ and 18o27’ N latitude and 74o50’ and 78o33’ E longitude, in the centre of the western peninsular India. The state has a topography ranging from the narrow stretch of coastal plains to the elevated terrains of the Western Ghats sloping gently to the West to the drier plateau regions in the East. The state has 30 revenue districts and can be divided into 10 agro-climatic zones: Northeastern transition, Northeastern dry, Northern dry, central dry, Eastern dry, Southern dry, Southern transition, Northern transition, Hilly, and Coastal. Each district consists of villages (29340 numbers for the state) where the majority of the livestock animal populations are reared by the farmers in small holdings (2-3 animals/household). All 30 revenue districts were included in the study.

Thirty five clinical materials (tongue epithelium and vesicular f luid) were collected from eighteen suspected FMD incidences from the state during 2014. The incidences were not extensive in nature, only 3 to 4 animals were affected in each episode and most of them were unvaccinated. The tissue samples were processed (chloroform extracted 10% PBS suspension) and serotype was confirmed using sandwich ELISA [8] at our laboratory and further by multiplex PCR [9] at the FMD central laboratory, Mukteswar, India.

A total of 7923 serum samples [Table 1]

Table1: Seroprevalence of FMD in livestock of Karnataka as assessed by NSP ELISA.

Species No. Tested % NSP positive (95%CI) χ2 for districts
  4639 35 (33.5-36)  
Cattle 444.5***
  1363 27 (25-30)  
Buffalo 181***
    12 (8.5-15)  
Sheep 1187 63***
    23 (19-28)  
Goat 734 57***

F= 10.42*** between the Species, ***significant at< 0.0001

(4639 cattle, 1363 buffalo, 1187 sheep, 734 goats) were collected from the ruminant population between May and August of 2014 by following a multistage convenience sampling. The sample size for the population was estimated [10]. Fifteen villages were selected in each district by using randomization calculator (RANDOM.ORG) and serum samples were collected from these villages following simple random sampling in which each member of the subset had an equal probability of being chosen with an unbiased representation. The serum samples were screened for antibodies against NSP and SP of FMDV.

Detection of Antibodies against NSP (NSP-Ab) Of FMDV in Bovines

The 3AB3 NSP-ELISA developed by Mohapatra et al., [11], validated and adopted as the primary screening assay for NSP serosurveillance in India, was employed for detecting the NSP-Ab in bovine serum samples. The 3AB3 NSP indirect ELISA was considered to be valid if the mean absorbance (OD) of the positive control was above 0.8, OD of the supplied negative control was less than 0.3 and the background was less than 0.10. The final result of each test serum was expressed as the Percent Positivity (PP) value and the sample was declared positive if PP value was more than 40 percent. The PP value was calculated by dividing the OD of the test serum by that of the positive control serum and then multiplying by 100.

Detection of Antibodies against NSP (NSP-Ab) Of FMDV in Small Ruminants

A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to FMDV [12] was used to screen serum samples collected from small ruminants. Th e serum samples were diluted (1:21) in the serum diluent buffer and assayed using the indirect ELISA format. The absorbance values of the positive control (ODpos ) and the samples (ODsample ) were corrected by subtracting the Optical Density (OD) of the negative control (ODneg ). The final result of each test serum was expressed as the Percent Positivity (PP) value and samples with a PP value of ≥25 relative to the normalized positive sample OD value were considered as positive and those below 25 as negative. Percent Positivity (PP) value for the sample was calculated by using the formula PP value = (ODsample-ODneg )*100/ (ODpos-ODneg ).

Single Dilution Liquid Phase Blocking ELISA (SdLPBE) For Quantitative Estimation of Antibody Levels against SP

Antibody titres to SP were quantified by SdLPBE as described by Sharma et al., [13]. The kit has been validated and adopted as the screening assay for seromonitoring of FMD control programme (FMDCP) in India. In brief, test serum samples were diluted to 1:32 and mixed individually with equal volume of pre-titrated inactivated whole virus antigen of the three serotypes making the final dilution of serum to 1: 64. Antigen–antibody mixtures were incubated at 4°C for overnight, and trapped/unblocked antigens were traced by the serotype-specific hyperimmune guinea pig serum. The OD values of the ELISA plates were analyzed using PDFMD ELISA Analyst version 2.0. The titers are presented in this study as log10 value. Antibody titer of log10 1.8 or more obtained by SdLPBE was adopted as cut off to categorize animals as potentially protected based on the sero monitoring data generated over the last ten years in the country [13].

Data Analysis

Statistical analysis of the data generated from the study was performed using survey toolbox for livestock diseases (Epitoolsepitools.ausvet.com.au/content.php). The alpha level was set at 0.05 and 95% confidence interval (CI 95% ) was calculated. Pearson’s Chi-square test was used to detect significant differences in the seropositivity between the species and between districts. If the probability value (P value) is less than or equal to set alpha level (0.05) then the result was considered as statistically significant. ANOVA was carried out to know the significant difference in SP level between the species and serotypes and also to know the significant difference in mean titres of NSP between species.

Results

Detection of FMDV Serotypes in Clinical Samples

During the year 2014, a total of 10 incidences were confirmed as FMD outbreaks from the processed clinical samples. FMD virus serotype ‘O’ was recovered from 10 clinical samples. Cattle were the main species affected (n=30) followed by pig (n=25). FMD incidence due to FMDV serotype O was confirmed in seven revenue districts.

Prevalence of Antibodies against FMDV NSP

A total of 33% bovines and 16% small ruminants were seroreactors in NSP ELISA. Overall, 35% of cattle, 27% of buffaloe, 12% of sheep and 23% of goats were seroreactors in NSP-ELISA [Table 2].

Table 2: District level seroprevalence of foot and mouth disease in ruminant population in Karnataka state, India.

      % NSP positive (95%CI)
District Livestock Population Animal Sampled Cattle Buffalo Bovine (Cattle& Buffalo) Goat Sheep Small ruminants (Goat &Sheep)
Bagalkote 1611199 300 33 30 31.5 20.3 22 21
(21.5-38) (11-31)
Bengaluru Urban 266794 248 43 75 44 0 7 4.2
(17-29) (3-8)
Bengaluru Rural 376564 249 22 0 22 24 7 12
(33.5-53) (10-15)
Belagavi 2718252 297 43 37 40 21.5 22 22
(11-23) (10.5-33)
Ballari 1417107 316 16 2 13 33 23 24
(37-56) (10-38)
Bidar 621789 250 46 54 50 5 10 6
(43-57) (10-12)
Chamarajanagar 512312 200 56 10 49.5 - - -
(43-56)
Chikkamagalur 1575522 297 7 7 7 27 3 12
(4-11) (1-26)
Chikkaballapur 833322 268 32 7 26.5 64 14 22
(21-33) (12-32)
Chitradurga 546118 301 52 25 47.5 0 1 1
(41-54) (0.4-2)
Dakshina Kannada 290594 253 27.5 - 27.5 21 0 21
(22-34) (9-32.5)
Davangere 924207 266 50.5 32 48 0 3 3
(41-55) (1-7)
Dharwad 413793 300 42 34 40 19 28.5 21
(33-47) (13-29)
Gadag 573822 246 45 51 47.5 25 11.5 17
(41-54) (6-29)
Hassan 1011052 250 39 25 35 26 9 18
(29-42) (4-32)
Haveri 768964 300 12.5 16 13.5 21 9 14
(9-19) (8-20)
Kalaburgi 1008178 240 23 28 25 32.5 0 32.5
(19.5-31) (11-54)
Kodagu 118885 200 30 31.5 30.5 - - -
(2.5-37)
Kolar 790330 234 38 17 37 0 3 3
(31-44) (0.3-6)
Koppal 1023493 350 14 14 14 0 11 11
(10-19) (3-19)
Mandya 1098738 254 42 - 42 0 4 4
(35-49) (1.5-9)
Mysuru 962065 253 30 0 30 0 8 7.5
(24-37) (0.3-15)
Raichur 1385051 301 11 4 9 22 20 21
(6-14) (3.5-38)
Ramanagara 542113 295 32 50 36.5 24 22 23
(30-43) (7-39)
Shivamogga 778723 300 38 21 35 28.5 12 18
(29-42) (3-33)
Tumakuru 1971345 250 26 17 24.5 5.5 0 2
(20-31) (0.3-4)
Udupi 240445 227 69.5 - 69.5 15 0 15
(63-75) (4-34)
Uttara Kannada 431181 235 52.5 52 52.5 53 35 4
(46-59) (11-69)
Vijapura 1095245 233 36 28 33 53 12.5 33
(27-40) (14-52.5)
Yadgiri 1113142 210 19 13 15.5 60 0 60
(33.5-36) (50-78)
Total for the State 27020345 7923 35 27 33.2 23 12 16
(33.5-36) (25-30) (32-34) (19-28) (8.5-15) (14-18)

The prevalence of anti-NSP antibodies varied significantly between the ruminant species (χ2 = 264.8 df =3 P<.0001) and between the districts [Table 2]. Comparison of mean titre of NSP revealed significant difference between the species (F=10.42, P<0.0001). Seroprevalence in cattle was higher than in buffalo (χ2 = 26.91, df = 1, p < 0.0001), sheep (χ2 =240.87, df =1 p < 0.0001) and goats (χ2 = 38.1, df = 1, p = 0.574). The seroprevalence varied significantly between large and small ruminants (χ2 = 205, df = 1, p < 0.0001) and also between small ruminants (χ2 = 44.14, df = 1, p < 0.0001).

Prevalence of Antibodies against FMDV SP

Antibodies to SP deemed to be protective (titer of log10 1.8 or more) (SP-Ab) were observed in 78% of bovines (cattle & buffaloes together) and 18% of the small ruminant samples against all three serotypes O, A and Asia-1. Species wise, 79% of cattle, 74% of buffalo, 17% of sheep and 18% of goat samples showed SP-Ab against all the three FMDV serotypes O, A and Asia-1. The SP-Ab was observed in 84%, 86% and 93% of the large ruminants (cattle/buffaloes) and 38%, 32% and 35% of the small ruminants (sheep/goats) against serotype O, A and Asia-1, respectively. The prevalence of SP-Ab varied significantly between bovines and small ruminants (F=55, p<0.0001), against all the three FMDV serotypes and also between individual serotypes O, A and Asia-1(F=53, P<0.0001). The samples negative for NSP antibodies in small ruminants (n=1611) revealed SP-Ab in 36% of the samples against serotype O, 31.6% against A, 35.8% against Asia-1 and 18.2% against all three serotypes. The samples positive for NSP antibodies in small ruminants (n=310) revealed SP-Ab in 49% of the samples against serotype O, 37% against A, 44.8% against Asia 1 and 21.3% against all three serotypes. Both NSP-Ab positivity and ≥4 fold spike of SP-Ab titre (0.6 log10 titre increase) was observed in 18% of the samples against any one of the three serotypes in small ruminants.

Discussion

FMD is endemic and known for its wider distribution in Karnataka state, India. The retrospective study on the epidemiology of Karnataka had revealed the dominance of FMDV serotype O over the other serotypes A and Asia-1 in causing the outbreaks in the livestock [3]. The confirmed outbreaks in the recent past revealed the circulation of all the three serotypes in the state, though outbreaks due to A and Asia-1 were intermittently detected [3]. FMDV serotype O is the predominant serotype in India and responsible for around 80% of the outbreaks in the country. The Southern region of the country, including the state of Karnataka had experienced severe outbreaks during 2013 due to sub-lineage O/ME-SA/ Ind2001d (5). During 2014, all the ten confirmed FMD incidencesin Karnataka were due to serotype O. The phylogenetic analysis based on VP1 (1D) coding region of serotype O virus collected during 2014-15 revealed extended dominance of Ind2001 strains and limited circulation of lineage PanAsia which had been identified to cause two sporadic incidence in the state [14]. Re-emergence of Pan- Asia lineage which had caused many outbreaks in 2006-07 in southern region of the country including Karnataka was considered as an epidemiologically significant event recorded during 2014. In spite of genetic heterogeneity, the serotype O viruses recovered from the Karnataka state were found to be antigenically homologous to current serotype O vaccine strain INDR2/1975 [14].

A systematic vaccination programme is ongoing in Karnataka state to control FMD. Under the programme, all the cattle, buffalo and pig populations are being bi-annually vaccinated with a trivalent vaccine since 2011. Earlier to the implementation of FMD-CP, there was no preventive vaccination against FMD in Karnataka, and vaccination was limited mostly to post-outbreak situations. With the implementation of FMD-CP, the vaccination coverage increased gradually from 58% in the first phase to 80% at the end of the fourth phase. The seromonitoring results indicated that the protective SP Ab against all the three serotypes increased gradually from 4.5% to 59% at the end of the fourth phase of vaccination, leaving 61% of the population susceptible to FMDV attack with anyone of the three serotypes, circulation of which has been incidentally confirmed [3]. Although clinical disease has been reduced in the state because of the systematic vaccinations, an abrupt increase in the number of FMD cases due to FMDV serotype O involving all the species was recorded in 2013 after four rounds of mass vaccination. Post-outbreak of the disease in 2013, the vaccination campaign was intensified and the vaccination coverage was more than 95 percent. The present study was carried out subsequent to two rounds of mass vaccination after the outbreaks in 2013.

The SP-Ab was observed in 79% of the large ruminants (cattle/ buffaloes) against all three serotypes. Post outbreak of the disease in 2013, due to increase in vaccine coverage, the SP-Ab increased from 59% to 79% against all three serotypes. These figures could be inclusive of both vaccine and infection induced protective antibodies against SP. The increase in SP-Ab and reduced disease incidence in the state may be due to infection (outbreak) immunity combined with extensive vaccination [15]. The increase in anti-NSP antibodies in bovines from 21% in 2013 to 33% in 2014 also indicates the circulation of the virus and exposure to infection. In India, only cattle, buffalo and pigs are vaccinated under FMDCP and small ruminants are not vaccinated. SP-Ab (titer of log10 1.8 or more) was observed in 18% of the small ruminant samples against all three serotypes O, A and Asia-1. As small ruminants are not covered in the vaccination programme adopted in the country, any evidence of SP-Ab in the flock should be considered as an outcome of FMDV infection, and serotype-specific spike in these tracer animals should be suggestive enough of the circulating serotype of the virus [16]. Since the circulation of all the three serotypes has been confirmed in the state of Karnataka, the presence of SP-Ab in small ruminants indicates that these animals were frequently exposed to all the three serotypes. In total, 18 percentage of the samples demonstrated ≥4 fold relative spike in SP-Ab titre against either of the serotypes further confirming the circulation of FMDV serotypes in small ruminants. Earlier published reports also revealed the circulation of FMDV serotypes in small ruminants [17-19]. Clear 4 fold spike in SP-Ab was not apparent in bovines, which could be because of a masking effect of vaccinal antibodies or post-infection due to serotypes other than that involved in the present infection [20]. From the above findings, it could be clearly inferred that the small ruminant populations are frequently exposed to FMDV infection by different serotypes of the virus and remain as sub-clinical host. It was observed in the present study that the samples negative for NSP antibodies in small ruminants revealed SP-Ab in 18.2% samples against all three serotypes. The samples positive for NSP antibodies in small ruminants revealed SP Ab in 21.3% of samples against all three serotypes. The presence of NSP antibodies in the animals negative for SP antibodies might have been due to residual antibodies arising from the past infection, as earlier study has shown that antibodies against NSP can persist for a longer duration than SP after infection [11]. The NSP-Ab positive but SP-Ab negative category could have been either due to a faster rate of decline of SP-Ab over time subsequent to an infection or due to a weaker SP-Ab response. Though it has been shown that following an infection, animals can remain seropositive to structural antibodies of FMDV for several years [21], the rate of decline of SP-Ab in small ruminants has been shown to be faster than that in cattle [22-23].

Overall, 35% of cattle, 27% buffaloe, 11.6% of sheep and 23.2% of goats were seroreactors in NSP-ELISA. The NSP ELISA results are indicative of the past exposure or ongoing virus activity in susceptible animals. Among small ruminants, prevalence was sig- nificantly higher in goats than in sheep. Lower seroprevalence of FMD in sheep may be associated with low frequency of exposure to the disease. In most of the field outbreaks, we have seen that only the bovine species show clinical manifestations and the small ruminants remain asymptomatic even though cohoused with the large ruminants. T he level of virus replication is relatively more luxuriant in bovines than in the small ruminants. Hence, the NSP-Ab response elicited in the infected bovines is expected to be comparatively high than the generally asymptomatic small ruminants. Besides, in ruminants, FMDV is capable of causing a persistent infection with a significant higher duration for cattle (about 3.5 years), than sheep (9 months) and goat (4 months) [24]. These factors related to variability in the degree of virus replication and persistence might have contributed to the observed difference in the apparent prevalence of NSP-Ab between large and small ruminant population. The small ruminants especially goats can be used as tracers when bovine population is routinely vaccinated under FMD-CP.

The study demonstrated that FMD is endemic in the state. The present study gathered the serological evidence of the virus activity in the small ruminant population of Karnataka state. The animal husbandry practice in the state reflects cattle, sheep and goats being reared in close proximity and at many places even co-housed in a single shed. Communal grazing is practiced in many areas where both small and large ruminants are allowed to use the same pasture land and water sources. These unrecognized, sub clinically infected small ruminants may act as a source of infection through their secretions and excretions and could pose a potential risk of virus dissemination to cattle and other animals. The preliminary findings of the present study suggest the need for strengthening the surveillance activities in small ruminants alongside large ruminant population.

Acknowledgement

We thank the Project Director, PD-FMD, ICAR, for providing all the logistics to conduct this study. We thank the Joint Director, (ICAR-Indian Veterinary Research Institute), for providing ABC kits and logistics to screen the small ruminant serum samples. We are grateful to the Department of Animal Husbandry and Veterinary Services, Government of Karnataka, for providing assistance in collecting serum samples. We sincerely thank all the farmers who permitted us to collect blood samples from their livestock. Critical review of the manuscript by Dr. Saravanan Subramaniam is also gratefully acknowledged.

References

1. Pattnaik B, Subramaniam S, Sanyal A, Mohapatra JK, Dash BB, Rajeev Ranjan, et al. Foot-and-mouth disease: global status and future road map for control and prevention in India. Agric Res. 2012; 1:132-147.

2. Venkataramanan R, Hemadri D, Bandyopadhyay SK, Taneja VK. Foot and mouth disease in India- present status. In Global roadmap for improving the tools to control foot-and-mouth disease in endemic settings and subsequent roadmap outputs. Report of a workshop held at Agra, India 29 November-1 December. 2006.

3. Hegde R, Gomes AR, Giridhar P, Kowalli S, Shivashankar BP, Sudharshana KJ, et al. Epidemiology of foot and mouth disease in Karnataka state, India: a retrospective study. Virus Dis. 2014; 25: 504-509.

4. Annual Report 2013-14: Project Directorate on foot and mouth Disease, Mukteswar.

5. Subramaniam S, Mohapatra JK, Sharma GK, Biswal JK, Ranjan R, Rout M, et al. Evolutionary dynamics of foot-and-mouth disease virus O/ME-SA/ Ind2001 lineage. Vet Microbiology. 2015; 178:181-189.

6. Sharma, GK, Mahajan S, Verma B, Matura R, Subramaniam S, et al. Epidemiological investigation of foot and mouth disease incidences in southern peninsular India during 2013. Open Session of the European Commission for the control of foot-and-mouth disease 29-31 October 2014 Cavtat, Croatia. 2014.

7. Annual Report 2013: AICRP FMD, Regional centre, Institute of Animal Health &Veterinary Biologicals, Bangalore.

8. Bhattacharya S, Pattnaik B, Venkataraman R. Development of an application of sandwich enzyme linked immunosorbent assay (ELISA) for type identification of foot-and-mouth disease virus in direct field materials. Ind J Anim Sci. 1996; 66:1-9.

9. Giridharan P, Hemadri D, Tosh C, Sanyal A, Bandyopadhyay SK. Development and evaluation of a multiplex PCR for differentiation of foot and-mouth disease virus strains native to India. Virol Meth. 2005; 126: 1-11.

10. Thrushfield M .Veterinary Epidemiology, 3rd edn. Blackwell Science, Oxford, UK. 2005.

11. Mohapatra JK, Pandey LK, Sanyal A, Pattnaik B. Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination. J Virol Meth. 2011; 177:184-192.

12. Hosamani M, Basagoudanavar SH, Tamil Selvan RP, Das V, Ngangom P, Sreenivasa BP, et al. A multi-species indirect ELISA for detection of non structural protein 3ABC specific antibodies to foot-and-mouth disease virus. Arch Virol. 2015; 160: 937-944.

13. Sharma GK, Mahajan S, Matura R, Subramaniam S, Mohapatra JK, Pattnaik B. Quantitative single dilution liquid phase blocking ELISA for sero-monitoring of footand- mouth disease in India. Biologicals. 2015 43:158-164.

14. Annual Report 2014-15: Project Directorate on Foot and Mouth Disease, Mukteswar.

15. Subramaniam S, Pattnaik B, Sanyal A, Mohapatra JK, Pawar SS, Sharma GK, et al. Status of foot-and-mouth disease in India. Transbound Emerg Dis. 2012; 60:197-203.

16. Balinda SN, Tjornehoj K, Muwanika VB, Sangula AK, Mwiine FN, Ayebazibwe C, et al. Prevalence estimates of antibodies towards foot-and-mouth disease virus in small ruminants in Uganda. Transbound Emerg Dis. 2009; 56: 362- 371.

17. Ranabijuli S, Mohapatra JK, Pandey LK, Rout M, Sanyal A, Dash BB, et al. Serological evidence of foot-and-mouth disease virus infection in randomly surveyed goat population of Orissa, India. Transbound Emerg Dis. 2010; 57: 448-454.

18. Rout M, Senapati MR, Mohapatra JK, Dash BB, Sanyal A, Pattnaik B. Serosurveillance of foot and mouth disease in sheep and goat population of India. Prev Vet Med. 2014; 113: 273-277.

19. Mohanty NN, Subramaniam S, Rout M, Sarangi LN, Bisht P, Laxmi Kant Pandey, et al. Serosurveillance of foot-and-mouth disease in ruminant population of Coastal Odisha, India. Benisuef Univ J Basic and Applied Sci. 2015; 4: 279-283.

20. Mwiine FN, Ayebazibwe C, Alexandersen S, Olaho-Mukani W, Okurut Ademun AR, Tjornehoj K. Seroepidemiological investigation of foot and mouth disease virus serotypes in cattle around Lake Mburo National Park in South-Western Uganda. J Vet Med and Animal Health. 2010; 2: 46-54.

21. Doel TR. Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol. 2005; 288: 103-131.

22. Cunliffe HR. Observation of duration of immunity in cattle after experimental infection with foot and mouth disease. Cornell Vet.1964; 54: 501-510.

23. Dellers RW, Hyde JL. Response of sheep to experimental infection with foot and mouth disease virus. Am J Vet Res. 1964; 25: 469-473.

24. Moonen P, Schrijver R. Carriers of foot and mouth disease virus: a review. Vet Quart. 2000; 22: 193-197.

Other Articles

Article Image 1

The Oncogenesis of John Cunningham Virus

The John Cunningham Virus (JCV) was isolated in culture from the brain of a case of Progressive Multifocal Leukoencephalopathy (PML) complicating Hodgkin’s disease. JCV contains icosahedral capsids that are composed of three structural viral proteins and small, circular, double-stranded DNA genomes. JCV is a member of the polyomaviridae family and infects a large proportion of the population worldwide and may cause PML upon immunodeficiency. When the immune system is defective, JCV may be activated. JCV can be found in tonsillar tissue, and the respiratory and digestive tracts are deemed to be the leading sites for JCV to enter human body. Transgenic mouse model showed that T antigen might induce lung and lens tumors with tissue specificity, which is not linked to alternative splicing of its intron. Taken together, T antigen is considered to play a significant role in JCV oncogenesis. In future, we will establish transgenic mice expressing T antigen in various cells using cell-specific promoter and clarify the pathomolecular mechanisms of T-antigen-related tumors and its tissue specificity of oncogenesis.

Lei Fang1 and Hua-chuan Zheng2*


Article Image 1

Effects of Antiviral Treatment on Chronic Hepatitis B-Related Hepatocellular Carcinoma and Recurrence after Surgical Treatment

Hepatocellular Carcinoma (HCC) is one of the most common and aggressive malignancies, and the high rate of recurrence is a major obstacle to improving prognosis. Chronic Hepatitis B Virus (HBV) is one of the major causes of HCC, and high viral replication rate and related hepatic inflammation are major risk factors of HCC recurrence after surgical resection. Current approved antiviral medications for the treatment of chronic hepatitis B are interferon-α (IFNα) and nucleos (t) ide analogues (NAs), including lamivudine, adefovir dipivoxil, telbivudine, entecavir, and tenofovir disoproxil fumarate. IFNα treatment significantly reduces HBV-related HCC in sustained responders, but its usage is limited by adverse effects. NAs treatment significantly reduces disease progression into cirrhosis and thus HCC incidence, especially in HBV e antigen-positive patients. However, the long-term continuous treatment of NAs may result in drug resistance due to viral mutations. The effect of IFNα treatment on HCC recurrence remains controversial, while evidence has suggested that postoperative NAs therapy can improve both recurrence-free survival and overall survival in patients with HBV-related HCC. There is a great need to develop more effective and affordable new agents with a better safety record. More high-quality prospective trials are needed to quantitatively estimate treatment efficacy and identify predictive factors of HCC development and progression.

Xiaomei Hou1, Jue Wang2 and Yan Du2*


Article Image 1

Advances in GCRV Research: Virus Molecular Type and Immunogen

Grass carp reovirus, GCRV, belongs to the genus Aquareovirus (AQRV). It is the most virulent species of AQRV, and infection by GCRV causes hemorrhagic disease in grass carp. A new strain, GCRV-GD108, was found in China. Significant differences were found between GCRV-GD108 and GCRV as well as between GCRVGD108 and other known AQRVs. Moreover, similarities were found between GCRV-GD108 and Orthoreovirus (ORV), suggesting a closer evolutionary relationship between GCRV-GD108 and ORV than between GCRVGD108 and the known AQRVs. The discovery of different virus molecular types of GCRV indicates the importance of molecular diagnosis and the development of a specific vaccine. Vaccines have been developed that include inactivated tissue vaccines, inactivated cell vaccines, and attenuated viral vaccines. Great efforts have been made in recent years to investigate immunogen for the preparation of genetically engineered vaccines, which are expected to provide protection for the cultured grass carp.

Xing Ye*and Yuan-yuan Tian


Article Image 1

The Power of GPR for Predicting Liver Fibrosis and Cirrhosis May Be Affected By Different Scoring Systems of Liver Fibrosis in Patients with Chronic Hepatitis B

We read with interest the article by Maud Lemoine et al [1] recently published in Gut. They found that Gamma-Glutamyl Transpeptidase (GGT)-to-Platelet Ratio (GPR) may be acted as a simple, non-invasive and inexpensive alternative to liver biopsy and Fibro scan laboratory model in sub-Saharan Africa. The GPR was significantly better than Aspartate Transaminase-To-Platelet Ratio Index (APRI) [2] and Fib-4 (based on age, ALT, AST and platelet count) [3] in predicting liver extensive fibrosis (≥F2) and cirrhosis (≥F4) in patients with Chronic Hepatitis B (CHB) in the Gambia and Senegal, but not in France. So we hypothesized that the predictive efficiency of these 3 markers may be heterogeneous in different race.

Xueping Yu1,2, Jiming Zhang2* and Zhijun Su1*


Article Image 1

Vital Role of Phylogenetic Analysis as Evidence in Illegal Investigation of Virus Transmission

During recent years phylogenetic analysis has become progressively popular as a tool for the criminal investigation of viral transmission, where it is used to derive the ancestral relationships of viral infections from sampled genome sequences. It has been used to cases involving the transmission of the fast-evolving human immunodeficiency virus (HIV) [1], Hepatitis B Virus (HBV) [2,3], hepatitis E (HEV) [4] and for tracking viral transmission in animal field. For example, for the first time phylogenetic analysis determined that the source of viral disease in aquaculture [5,6,7]. Aspects of the transmission of these viruses are impressed on the genetic variation of genomes [8]. These data revealed information about the patterns of virus emergence, viral epidemiology and evolutionary dynamics [9,8]. Analysis of molecular phylogenetic relationships must be based on a domain with a suitable level of evolution for the issue under investigation. Evaluation of recent transmission events requires the analysis of fast-evolving regions, whereas older events must be studied by sequencing more stable regions [2]. This analysis investigates small difference in virus genome using computational methods to calculate the variation between strains of viruses. This process is a critical complex scientific process which undertaken by virologist. The result of phylogenetic analysis has recently applied in illegal trials as evidence of responsibility for virus transmission [10]. In these events, the expert analysis of virologist has been discovered to be of critical importance. In the other hand, these trials can be applied to acquit individuals and keep out the possibility that defendant was responsible for virus transmission [10,11,8]. It is important to note that molecular analysis cannot prove the transmission virus between two individual, but it can support any information on the direction of that transmission [10,1]. It is necessary for molecular phylogenetic analysis to use the right comparison samples, because inappropriate samples could overstate the relationship between two viruses (of different geographical origin) as being conspicuously unique. In addition, many viruses frequently recombine and cause further opportunity for genetic novelty viral transmission from data commonly based on phylogenetic analysis [8]. Also, models of virus transmission and early diversification are the most important result of phylogenetic study. For example, Zika virus emerged in Africa and now circulates on all inhabited continents [12,13]. In another study demonstrated that isolated Dengue virus type 1 strain from Indonesia has a close phylogenetic relationship with strains of Japan [14]. In the recent decade, phylogenetic studies have matured with focus on the human RNA viruses such as influenza virus, HIV, dengue virus and HCV [8-10,15]. However, there are wide ranges of viruses to which phylogenetic analysis are used [9,16-18]. This review shortly outlines the importance of phylogenic analysis for viral transmission with focus on virus origin and shows phylogenetic approach to identify ecological and biological of virus transmission.

Maryam Dadar*


Article Image 1

Discovery and Roles of Virus-Encoded RNA Silencing Suppressors

RNA silencing is a general surveillance system in plants and animals which could protect hosts from virus infection. However, many virus species survived by expressing a series of proteins named as RNA Silencing Suppressors (RSSRs) to counteract this defense system. This review elaborated the newly discovered RSSRs encoded by virus including the recently discovered polymerase slippage product and some newly-identified RSSRs in mammalian cells. This review will also provide a comprehensive understanding of the role of RSSRs during the virus infection, especially with regard to its newly identified function in epidemic modification in hosts.

Ma Lin*


Article Image 1

Zika and Its Preparedness in Nepalese Scenario

Zika virus came to known to public in 1947, when it was first isolated from a Rhesus monkey from Uganda [1-3]. Due to its unremitting spread in past decade, zika virus created havoc and gained its recognition as one of the prominent threat in public health across the globe [4-7]. In the March of 2015, Brazil confirmed its first zika infection. Following the zika cases, country had to face erupted increment in microcephaly cases [8]. In next nine month span, the cases of microcephaly increased from 150 cases to 400. After observing this trend, PAHO (Pan American Health Organization) issued an epidemiological alert on December 1st 2015, warning a suspected link between Zika and microcephaly [9].

Bishnu Prasad Upadhya1, Rajani Malla1, Krishna Das Manandhar1, Birendra Prasad Gupta2*, Anurag Adhikari2 , Ramanuj Rauniyar3, Chirik Shova Tamarkar4 , Bimlesh Kumar Jha5 and Roshan Kurmi6


Article Image 1

Long-Term Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferas

Background: The Alanine Aminotransferase (ALT) level is considered as a risk factor for the progression to liver cirrhosis and Hepatocellular Carcinoma (HCC) in patients infected with Hepatitis B Virus (HBV) and remains a subject of debate.

Methods: We prospectively compared the incidence of HCC between HBV infected patients with normal ALT and those with elevated ALT.

Result: A total of 378 HBV-infected patients (102 with normal ALT and 276 with elevated ALT) were included. The median follow-up period was 8.2 years. The incidence rates of HCC development were significantly lower in the normal ALT patients than in patients with elevated ALT (0.55 vs 2.20 per 100 person-years, P = 0.021, while the incidence rates of hepatic decompensation (0.43 vs 1.23 per 100 person-years) and survival (53.8% vs 47.4% at 10 years) did not significantly differ between the two groups (Kaplan-Meir analysis). The main causes of death were on-hepatic diseases in patients with normal ALT. Multivariate Cox analyses model revealed that the risk of HCC was lower in patients with normal ALT than in patients with elevated ALT (hazard ratio (HR), 0.28, Confidence intervals (CI) (0.14-0.78)), while the risk of hepatic decompensation and mortality was the same in the two groups of patients.

Conclusion: The risk for HCC and liver decompensation normal ALT was markedly reduced in HBV-patients with normal ALT. Aged patients with HBV with normal ALT should therefore maintain long-term surveillance for HCC. Future studies aimed to better identify those with remaining long-term risk for HCC are needed.

Blaise K Kutala1,2,3*, Emilie Estrabaud1 , Nathalie Boyer2,3, Corinne Castelnau³, Nathalie Giuily2,3, T Asselah1,3 and P Marcellin1,2,3


Article Image 1

LncRNA: A Rising Star in Virus-Host Cross-Talk during HIV-1 Infection

The Human Immunodeficiency Virus (HIV) is a retrovirus that has been aroused worldwide concern, due to its chronic and persistent infection, ultimately leading to a causal result of Acquired Immunodeficiency Syndrome (AIDS). Long noncoding RNAs (lncRNAs) are non-protein coding transcript longer than 200 Base Pairs (bp) and being considered to be key regulators that involved in various biological processes, such as chromatin modification, transcriptional regulation, post-transcriptional regulation, intracellular trafficking and etc. What deserves to be noticed is that lncRNAs are recently being reported to link with viruses closely, and lncRNAs are differentially expressed after a variety of virus infections, including HIV-1 infection. In this paper, we review the rapidly advancing field of lncRNAs, focus on the current progress of lncRNAs in HIV-1 infection, and briefly discuss their different roles in host gene regulation and viral replication during the establishment or maintenance of viral latency. Interestingly, lncRNAs may emerge as novel biomarkers of antiviral drugs and provide potential targets for new therapeutics of AIDS.

Liujun Chen1 , Shanshan Xu1 , Luoshiyuan Zuo3 , Song Han1,2, Jun Yin1,2, Biwen Peng1,2, Xiaohua He1,2 and Wanhong Liu1,2*


Article Image 1

Fungal Viruses: Promising Fundamental Research and Biological Control Agents of Fungi

Fungal viruses (mycoviruses) exist in all major groups of fungi. The primary focus of this review is viruses of filamentous fungi, especially plant pathogens, with emphasis on the molecular characterization of fungus-virus interactions. There are two main hypotheses about the origin of mycoviruses isolated from plant pathogenic fungi. The origin of these mycoviruses may be ancient but they may also have evolved from plant viruses. Many characterized mycoviruses are in unencapsidated dsRNA forms without any coat protein in fungi. Mycoviruses are efficiently spread in two ways, vertically by spore formation and horizontally via hyphal fusion. Replication cycle of RNA mycoviruses doesn’t have the extracellular route of infection under natural conditions. Typically, fungal infections cause no obvious phenotypic alterations. Although the interaction of mycoviruses and their host is largely limited, those aspects including the transcriptional profiling and RNA silencing are of help to understand the co-existence mechanism of virus and fungi. Mycoviruses are potential agents of biological control of important plant pathogenic fungi.

Shuangchao Wang1,2, Marc Ongena2 , Dewen Qiu1 and Lihua Guo1*